Testing effectiveness (Phase 2)Active Not RecruitingNCT03331250
What this trial is testing
Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)
Who this might be right for
AngiosarcomaEpithelioid Hemangioendothelioma
Massachusetts General Hospital 13